HUMAN CELLULAR MODEL SYSTEMS

For compound screening and

neuroscience research

WELCOME TO NEURIX

There are currently more than 600 diseases characterized as affecting the central nervous system which inflict neural damage. Unfortunately, few of these conditions have effective treatments available. Neurix is committed to pursue innovation and breakthrough technologies to disrupt the negative trend.

NEWS, EVENTS & INNOVATIONS

Coronavirus: our services are operational

Because your research counts we prioritize on providing full efficiency services, while decrease internal development to protect our employees from coronavirus.

We develop a coronavirus screening platform

For the identification of promising therapeutic compounds inhibiting viral replication, viral entry or viral-mediated host cell toxicity.

Meet us at the Swiss Biotech Day

September 15th 2020

Basel, Switzerland

WE KEEP YOU UPDATED

You want to hear about the last advances of our technology ? Please provide us you contact details to keep you updated. (not efficient on firefox browser)

3-DIMENSIONAL NEURAL TISSUE

Neurix provides services for drug discovery and development. We generate physiologically relevant 3-dimensional neural tissues derived from human pluripotent stem cells. Our organoids display accelerated cell maturity that mimic the native brain tissue. Predictive, accurate and reproducible, our in vitro human cell-based services enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
 

We generate two formats of neural organoids to ensure compatibility with high troughtput screening, and optimal disease modeling services

MiniBrain

TM

- Injectable

- Full genomic / proteomic analysis

Neurosphere

- High throughput compatible

OUR SERVICES 

Neurix provides human stem cell-based services for neural drug screening and lead compound validation including Efficacy & Drug Discovery services, as well as Cell Models.

BlastomaBrain      Glioblastoma invasion model

Glioblastoma invading neural organoids to asses drug efficiency on tumor growth, motility and metastasis.

TM

TM

VirionBrain      Gene therapy testing
                                Virus invasion model

Assessing the efficiency for gene therapies and anti-viral drug compounds.

CellBrain    Cell therapy testing

                            Biomaterial therapy testing

Testing the efficiency of cell therapy, cell survival and integration inside the neural tissue

TM

Personalized service

Neurix offers drug discovery services and personalized development of in vitro disease models, assays, and in dept -omic analyses. 

64, Avenue de la Roseraie
1205, Genève - Switzerland

+41 223 794 643

info@neurix.ch

BACK TO THE TOP

© 2019 by Neurix SA